Literature DB >> 1217841

Fetal prognosis in obstetric hepatosis.

T Laatikainen, E Ikonen.   

Abstract

116 women with obstetric hepatosis gave birth in the years 1971-1972 at the First and Second Departments of Obstetrics and Gynaecology, University Central Hospital, Helsinki. This accounts for a 1.1% incidence of all deliveries at this hospital. During most of these pregnancies fetal well-being was monitored by amnioscopy, by the oxytocin challenge test, by maternal urinary oestriol determinations and by estimating the fetal biparietal diameter weekly. In 38% of these pregnancies, signs of fetal distress were found, mainly an abnormal heart rate, or heart rate pattern, and/or meconium-stained amniotic fluid. These led to increased frequencies of induction of labour and of Caesarean sections performed because of asphyxia or imminent asphyxia as compared with a control group with similar age and parity distribution. There was an increase in the occurrence of twin pregnancies in the hepatosis series (7.6%). There were 4 intrauterine and altogether 8 perinatal losses of 125 infants born to hepatosis mothers. These observations suppport the opinion that there are increased risks for the fetus in pregnancies complicated by obstetric hepatosis. Amnioscopy and fetal heart rate recording during the delivery and oxytocin challenge test were found to be valuable in monitoring the fetal condition. The use of oestriol determinations, at least by employing the method in general clinical practice, was found to be of limited value in the predictive assessment of fetal distress in hepatosis. This might be due to impurities disturbing the determinations or to changed oestrogen metabolism in cholestasis.

Entities:  

Mesh:

Year:  1975        PMID: 1217841

Source DB:  PubMed          Journal:  Ann Chir Gynaecol Fenn        ISSN: 0003-3855


  14 in total

Review 1.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

2.  Operative delivery rates following induction of labour for obstetric cholestasis.

Authors:  Jessica R Webster; Lucy Chappell; Floria Cheng; Andrew C G Breeze; Nuala Lucas; Felicity Plaat; Catherine Williamson
Journal:  Obstet Med       Date:  2011-05-24

3.  Pruritus in pregnancy: a study of anatomical distribution and prevalence in relation to the development of obstetric cholestasis.

Authors:  A P Kenyon; R M Tribe; C Nelson-Piercy; J C Girling; C Williamson; P T Seed; S Vaughan-Jones; A H Shennan
Journal:  Obstet Med       Date:  2010-03-04

4.  Obstetric cholestasis.

Authors:  J B Weaver
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

Review 5.  Genetics of familial intrahepatic cholestasis syndromes.

Authors:  S W C van Mil; R H J Houwen; L W J Klomp
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

Review 6.  Interventions for treating cholestasis in pregnancy.

Authors:  Vinita Gurung; Philippa Middleton; Stephen J Milan; William Hague; Jim G Thornton
Journal:  Cochrane Database Syst Rev       Date:  2013-06-24

7.  Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.

Authors:  Hyo-Eon Jin; Soon-Sun Hong; Min-Koo Choi; Han-Joo Maeng; Dae-Duk Kim; Suk-Jae Chung; Chang-Koo Shim
Journal:  Pharm Res       Date:  2008-11-11       Impact factor: 4.200

8.  Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy.

Authors:  M Savander; A Ropponen; K Avela; N Weerasekera; B Cormand; M-L Hirvioja; S Riikonen; O Ylikorkala; A-E Lehesjoki; C Williamson; K Aittomäki
Journal:  Gut       Date:  2003-07       Impact factor: 23.059

9.  Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid.

Authors:  M H Davies; R C da Silva; S R Jones; J B Weaver; E Elias
Journal:  Gut       Date:  1995-10       Impact factor: 23.059

Review 10.  Intrahepatic cholestasis of pregnancy.

Authors:  Thomas Pusl; Ulrich Beuers
Journal:  Orphanet J Rare Dis       Date:  2007-05-29       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.